These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 16438040)

  • 1. Probing the Use of Triphenyl Phosphonium Cation for Mitochondrial Nucleoside Delivery.
    Guiraud M; Ali LMA; Gabrieli-Magot E; Lichon L; Daurat M; Egron D; Gary-Bobo M; Peyrottes S
    ACS Med Chem Lett; 2024 Mar; 15(3):418-422. PubMed ID: 38505859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. n-Tuples on Scaffold Diversity Inspired by Drug Hybridisation to Enhance Drugability: Application to Cytarabine.
    García-Castro M; Fuentes-Rios D; López-Romero JM; Romero A; Moya-Utrera F; Díaz-Morilla A; Sarabia F
    Mar Drugs; 2023 Dec; 21(12):. PubMed ID: 38132958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Versatile synthesis of amino acid functionalized nucleosides via a domino carboxamidation reaction.
    Gheerardijn V; Van den Begin J; Madder A
    Beilstein J Org Chem; 2014; 10():2566-72. PubMed ID: 25383128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of nucleoside phosphate and phosphonate prodrugs.
    Pradere U; Garnier-Amblard EC; Coats SJ; Amblard F; Schinazi RF
    Chem Rev; 2014 Sep; 114(18):9154-218. PubMed ID: 25144792
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficient synthesis of exo-N-carbamoyl nucleosides: application to the synthesis of phosphoramidate prodrugs.
    Cho JH; Coats SJ; Schinazi RF
    Org Lett; 2012 May; 14(10):2488-91. PubMed ID: 22554490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Special feature of mixed phosphotriester derivatives of cytarabine.
    Gouy MH; Jordheim LP; Lefebvre I; Cros E; Dumontet C; Peyrottes S; Périgaud C
    Bioorg Med Chem; 2009 Sep; 17(17):6340-7. PubMed ID: 19674903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of n-squalenoyl cytarabine and evaluation of its affinity with phospholipid bilayers and monolayers.
    Sarpietro MG; Ottimo S; Giuffrida MC; Rocco F; Ceruti M; Castelli F
    Int J Pharm; 2011 Mar; 406(1-2):69-77. PubMed ID: 21219999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prodrugs of Ara-CMP and Ara-AMP with a S-acyl-2-thioethyl (SATE) biolabile phosphate protecting group: synthesis and biological evaluation.
    Bazzanini R; Manfredini S; Durini E; Gröschel B; Cinatl J; Balzarini J; De Clercq E; Imbach JL; Périgaud C; Gosselin G
    Nucleosides Nucleotides; 1999; 18(4-5):971-2. PubMed ID: 10432722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the conjugate between N4-(4-carboxybutyryl)-1-beta-D-arabinofuranosylcytosine and chitosan as a macromolecular prodrug of 1-beta-D-arabinofuranosylcytosine.
    Ichikawa H; Onishi H; Takahata T; Machida Y; Nagai T
    Drug Des Discov; 1993; 10(4):343-53. PubMed ID: 8148473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoassemblies from amphiphilic cytarabine prodrug for leukemia targeted therapy.
    Liu J; Zhao D; He W; Zhang H; Li Z; Luan Y
    J Colloid Interface Sci; 2017 Feb; 487():239-249. PubMed ID: 27776282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic approaches to a mononucleotide prodrug of cytarabine.
    Bazzanini R; Gouy MH; Peyrottes S; Gosselin G; Périgaud C; Manfredini S
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(10-12):1635-49. PubMed ID: 16438040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of cytarabine prodrugs and delivery systems for leukemia treatment.
    Chhikara BS; Parang K
    Expert Opin Drug Deliv; 2010 Dec; 7(12):1399-414. PubMed ID: 20964588
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.